Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers

Summary

This study will examine the efficacy of a computerized cognitive behavioral therapy (CCBT) program for children with anxiety disorders in community health centers. The first phase of the study will offer insight into the feasibility of providing this intervention in community health centers, while the second phase will compare CCBT to treatment as usual.

Conditions

• Generalized Anxiety Disorder
• Social Phobia
• Separation Anxiety Disorder

Interventions

BEHAVIORAL

Computerized Cognitive Behavioral Therapy

Those who choose to participate will be enrolled in the 14 week study (18 weeks for phase II). They will required to attend 3 assessments - pre-treatment (week 0), mid-treatment (week 8), and post-treatment (week 14) (and a 4th assessment for a 1 month Follow-up for Phase II at week 18). This group will follow the CCBT protocol (Camp Cope-A-lot), which is the computer-assisted intervention for anxious children being examined in this study. The first 6 levels of this program are skill building levels to be completed by the user in his/her own home. The remaining 6 levels are completed with the therapist and consist of exposure tasks and rehearsal geared toward each child.

BEHAVIORAL

Treatment as usual

Those who choose to participate will be enrolled in the 14 week study (18 weeks for phase II). They will required to attend 3 assessments - pre-treatment (week 0), mid-treatment (week 8), and post-treatment (week 14) (and a 4th assessment for a 1 month Follow-up for Phase II at week 18). Those in this group will not receive the CCBT, and instead will undergo therapy for their anxiety as they usually would, whether by using medication or working with a therapist.

Sponsors & Collaborators

• University of South Florida

  lead OTHER

• Access Behavioral Health

  collaborator OTHER

• Henderson Behavioral Health

  collaborator UNKNOWN

• Directions for Mental Health

  collaborator UNKNOWN

Principal Investigators

• Eric A Storch, Ph.D. · University of South Florida

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

7 Years

Max Age

13 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2011-08-31

Primary Completion

2015-12-31

Completion

2015-12-31

Countries

• United States

Study Locations